INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. [PDF]
Colombo N +41 more
europepmc +1 more source
[2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico]. [PDF]
González-Zago A +5 more
europepmc +1 more source
Ovarian sex cord tumor with annular tubules: case report and review of the literature [PDF]
Ruiz-Echeverría FR +5 more
europepmc +1 more source
Eight-step laparoscopic repair of accidental large vessel injury [PDF]
Sanabria-Serrano DE +4 more
europepmc +1 more source
[Hidradenitis Suppurativa: Most Relevant Epidemiological Characteristics of an Underdiagnosed Disease. A Cross-Sectional Study] [PDF]
Abeledo LS +6 more
europepmc +1 more source
[Referral criteria to clinical genetics from primary care: Consensus document]. [PDF]
Ejarque Doménech I +7 more
europepmc +1 more source
La reutilización de biomarcadores para otros fines: oportunidades y dificultades en el cambiante campo de la medicina de laboratorio. [PDF]
Gruson D +3 more
europepmc +1 more source
Letter to the Editor about “Preoperative neutrophil/ lymphocyte ratio as prognostic factor in epitelial ovarian cancer” [PDF]
Cesar Huamanciza LÁ.
europepmc +1 more source
Índice de Masa Corporal como factor de riesgo para Cáncer en Población del Estado de México [PDF]
Karam Calderón, Miguel Ángel +1 more
core
[Reply to the letter to the Editor about “Preoperative neutrophil/lymphocyte ratio as prognostic factor in epitelial ovarian cancer”]. [PDF]
Vázquez Rojo J.
europepmc +1 more source

